solventum - Search News

Solventum Stock Jumps

Solventum Stock Jumps After $4.1B Deal With Thermo Fisher

Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.

GEN · 19h

Thermo Fisher Scientific Agreed to Acquire Solventum’s Purification and Filtration Business

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Reuters on MSN · 4d

Thermo Fisher Buys Solventum's Purification and Filtration Business for $4.1 Billion

(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion, sending the latter's shares up around 9%.

Solv, Q4 EPS

The Motley Fool on MSN · 1d

Solventum: Q4 EPS Beats, Cash Flow Dips

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.

Business Insider · 1d

Solventum reports Q4 EPS $1.41, consensus $1.31

Reports Q4 revenue $2.074B, consensus $2.05B. “Solventum (SOLV) executed another quarter of solid performance, enabling us to deliver full year

The News-Times · 1d

Solventum: Q4 Earnings Snapshot

The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.31 per share. The health care company posted revenue of $2.07 billion in the period, which also topped Street forecasts.

19hon MSN

Solventum Corp. stock falls Friday, underperforms market

Shares of Solventum Corp. shed 4.42% to $79.75 Friday, on what proved to be an all-around positive trading session for the ...

2don MSN

Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business

Activist investor Trian Fund Management plans to push Solventum to separate more of its businesses after the company’s $4.1 ...

Solventum forecasts annual profit above estimates on strong surgical product sales

M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.

Solventum In The Early Stages Of A Multiyear Turnaround Effort

Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...

Solventum price target raised to $84 from $75 at Piper Sandler

Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Solventum Stock Jumps

Solv, Q4 EPS

Related topics